1h Free Analyst Time
Boiron SA (BOI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.Speak directly to the analyst to clarify any post sales queries you may have.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
Highlights
Boiron SA (Boiron) is a pharmaceutical company that develops, manufactures and commercializes homeopathic medicines. The company manufactures its products through vegetable, animal, mineral or chemical origins. Its product portfolio comprises Camilia, Arnigel, Oscillococcinum, HomeovoX, Sedatif PC, Coryzalia, Arnicalme, Homeoptic and Stodal. Boiron’s products are used for the treatment of fever, chills, headaches, aches, coughs, muscle fatigue, bruising, contusions and others. The company has operational presence in Western Europe, Central Eastern and Europe and North America. It also manages production facilities in France and Belgium. Boiron is headquartered in Sainte-Foy-les-Lyon, France.
Boiron SA Key Recent Developments
Mar 14, 2018: BOIRON: 2017 results
Sep 07, 2017: BOIRON: 2017 half year results
Jul 20, 2017: Boiron: 2017 Half-year Activity
Reasons to buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Section 1 - About the Company- Boiron SA - Key Facts
- Boiron SA - Key Employees
- Boiron SA - Key Employee Biographies
- Boiron SA - Major Products and Services
- Boiron SA - History
- Boiron SA - Company Statement
- Boiron SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Section 2 - Company Analysis
- Boiron SA - Business Description
- Business Segment: Non-Proprietary Homeopathic Medicines
- Overview
- Performance
- Business Segment: OTC Specialties
- Overview
- Performance
- Business Segment: Other
- Overview
- Performance
- Geographical Segment: Europe excluding France
- Performance
- Geographical Segment: France
- Performance
- Geographical Segment: North America
- Performance
- Geographical Segment: Other Countries
- Performance
- Boiron SA - SWOT Analysis
- SWOT Analysis - Overview
- Boiron SA - Strengths
- Boiron SA - Weaknesses
- Boiron SA - Opportunities
- Boiron SA - Threats
- Boiron SA - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
- Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
- Boiron SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
- Boiron SA, Recent Deals Summary
Section 4 - Company’s Recent Developments
- Mar 14, 2018: BOIRON: 2017 results
- Sep 07, 2017: BOIRON: 2017 half year results
- Jul 20, 2017: Boiron: 2017 Half-year Activity
Section 5 - Appendix
- Methodology
- About
- Contact
- Disclaimer
List of Tables
- Boiron SA, Key Facts
- Boiron SA, Key Employees
- Boiron SA, Key Employee Biographies
- Boiron SA, Major Products and Services
- Boiron SA, History
- Boiron SA, Subsidiaries
- Boiron SA, Key Competitors
- Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
- Boiron SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
- Boiron SA, Recent Deals Summary
List of Figures
- Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
- Boiron SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Samples
LOADING...
Companies Mentioned
A selection of companies mentioned in this report includes:
- Virbac Group
- The Nature’s Bounty Co
- Nelson & Co Ltd
- Biologische Heilmittel Heel GmbH
- Arkopharma Laboratories SA
